23andMe Holding (ME) EV/EBITDA: History & Chart

23andMe Holding Co. (ME)ME23andMe Holding Co.

About 23andMe Holding Co.

23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected via their proprietary kit. These reports offer insights into customers' genetic ancestral origins, predispositions to certain personal health risks, the likelihood of being a carrier for rare conditions that could be passed to offspring, and how their genetic makeup might influence responses to various medications. The Therapeutics segment is dedicated to pharmaceutical research and development, focusing on the discovery and advancement of novel treatments aimed at improving patient well-being across diverse medical fields, including oncology, respiratory, and cardiovascular diseases. This segment also engages in the out-licensing of intellectual property associated with identified drug targets that are progressing through clinical development. 23andMe maintains a strategic partnership with GlaxoSmithKline Intellectual Property (No.3) Limited, leveraging genetic insights to validate, develop, and ultimately commercialize new pharmaceutical products. Established in 2006, the company's corporate headquarters are situated in South San Francisco, California.

South San Francisco, CA

560 employees

www.23andme.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Joseph Selsavage

View full financials

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
23andMe Holding Co. (ME)	$15.31M	N/A	N/A	N/A	N/A
NRC Health (NRC)vs ›	$439.69M	22.09x	14.36x	15.04x	16.70x
Shoulder Innovations, Inc. (SI)vs ›	$471.59M	N/A	N/A	N/A	N/A
Teladoc Health, Inc. (TDOC)vs ›	$1.21B	46.63x	40.09x	242.55x	242.55x
TransMedics Group, Inc. (TMDX)vs ›	$2.64B	24.90x	38.72x	90.49x	90.49x
DENTSPLY SIRONA Inc. (XRAY)vs ›	$2.68B	8.47x	7.67x	39.65x	28.44x
Hims & Hers Health, Inc. (HIMS)vs ›	$6.19B	72.93x	65.32x	316.83x	316.83x
Tempus AI, Inc. (TEM)vs ›	$7.69B	N/A	N/A	N/A	N/A
Oscar Health, Inc. (OSCR)vs ›	$8.09B	148.81x	107.51x	53.75x	53.75x
Bio-Rad Laboratories, Inc. (BIO)vs ›	$8.80B	22.04x	21.11x	19.54x	21.75x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

23andMe Holding Co. (ME)

$15.31M

N/A

NRC Health (NRC)vs ›

$439.69M

22.09x

14.36x

15.04x